These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2852967)

  • 1. Auricular microelectrostimulation: naloxone-reversible attenuation of opiate abstinence syndrome.
    Malin DH; Murray JB; Crucian GP; Schweitzer FC; Cook RE; Skolnick MH
    Biol Psychiatry; 1988 Dec; 24(8):886-90. PubMed ID: 2852967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of morphine withdrawal signs in the rat after chronic treatment with naloxone.
    Suzuki T; Fukagawa Y; Misawa M
    Eur J Pharmacol; 1990 Mar; 178(2):239-42. PubMed ID: 2158457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of morphine abstinence syndrome by body electroacupuncture of different frequencies in rats.
    Han JS; Zhang RL
    Drug Alcohol Depend; 1993 Jan; 31(2):169-75. PubMed ID: 8382148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of morphine withdrawal to naloxone by interferon.
    Dafny N; Zielinksi M; Reyes-Vazquez C
    Neuropeptides; 1983 Oct; 3(6):453-63. PubMed ID: 6420721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal brain stimulation attenuates morphine withdrawal behaviors.
    Beaulieu CL; Thorn BE
    Behav Neurosci; 1986 Aug; 100(4):504-11. PubMed ID: 3017375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of response-disruptive and somatic indices of opiate withdrawal during the initiation and development of opiate dependence.
    Schulteis G; Heyser CJ; Koob GF
    Behav Pharmacol; 1999 May; 10(3):235-42. PubMed ID: 10780239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three different types of alpha-interferons alter naloxone-induced abstinence in morphine-addicted rats.
    Dafny N; Reyes-Vazquez C
    Immunopharmacology; 1985 Feb; 9(1):13-7. PubMed ID: 4039302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous electrical stimulation with Limoge current potentiates morphine analgesia and attenuates opiate abstinence syndrome.
    Auriacombe M; Tignol J; Le Moal M; Stinus L
    Biol Psychiatry; 1990 Oct; 28(8):650-6. PubMed ID: 2173629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine.
    Cappendijk SL; Fekkes D; Dzoljic MR
    Behav Brain Res; 1994 Nov; 65(1):117-9. PubMed ID: 7880450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of precipitated withdrawal in rats acutely dependent on morphine.
    Ramabadran K
    Jpn J Pharmacol; 1985 Apr; 37(4):307-16. PubMed ID: 2989597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence.
    Wang Z; Bilsky EJ; Porreca F; Sadée W
    Life Sci; 1994; 54(20):PL339-50. PubMed ID: 7514710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence.
    Malin DH; Lake JR; Hammond MV; Fowler DE; Rogillio RB; Brown SL; Sims JL; Leecraft BM; Yang HY
    Peptides; 1990; 11(5):969-72. PubMed ID: 2284204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-cranial electrical stimulation attenuates the severity of naloxone-precipitated morphine withdrawal in rats.
    Dougherty PM; Dafny N
    Life Sci; 1989; 44(26):2051-6. PubMed ID: 2747416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance and dependence of dorsal horn neurones of the cat: the role of the opiate receptors of the substantia gelatinosa.
    Johnson SM; Duggan AW
    Neuropharmacology; 1981 Nov; 20(11):1033-8. PubMed ID: 6275287
    [No Abstract]   [Full Text] [Related]  

  • 17. A demonstration of naloxone-precipitated opiate withdrawal on single neurones in the morphine-tolerant/dependent rat brain.
    Fry JP; Herz A; Zieglgänsberger W
    Br J Pharmacol; 1980 Mar; 68(3):585-92. PubMed ID: 6132637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sites of action of naloxone in precipitating withdrawal jumping in morphine-dependent mice: investigations by the ED50 value and CNS content of naloxone.
    Miyamoto Y; Takemori AE
    Drug Alcohol Depend; 1993 Apr; 32(2):163-7. PubMed ID: 8389690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analog of neuropeptide FF attenuates morphine abstinence syndrome.
    Malin DH; Lake JR; Leyva JE; Hammond MV; Rogillio RB; Arcangeli KR; Ludgate K; Moore GM; Payza K
    Peptides; 1991; 12(5):1011-4. PubMed ID: 1800944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.